to determine the maintenance of pharmacodynamic effects of fenoldopam mesylate , a dopamine-1 agonist , the invasive hemodynamic profiles of 33 patients with new york heart association functional class iii to iv congestive heart failure were examined .
C0700481
fenoldopam mesylate
C0018802
heart